Shawver Laura (CIK 0001551891)

Latest company ownership

SPRY - ARS Pharmaceuticals, Inc.

Role: Director

Shares held

27,493

Last filed at

Apr 8, 2025

Confidence Score

47.9

2025Q4

Confidence Score History

2022Q4 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Apr 7, 2025	Apr 8, 2025	ARS Pharmaceuticals, Inc.	Director	Sell	17.5	-50,002	-19.21%	✓	$615.1K
Mar 5, 2025	Mar 7, 2025	ARS Pharmaceuticals, Inc.	Director	Sell	22.5	-50,000	-10.62%	✓	$560.4K
Feb 3, 2025	Feb 4, 2025	ARS Pharmaceuticals, Inc.	Director	Sell	17.5	-50,000	-19.21%	✓	$615.6K
Jan 6, 2025	Jan 7, 2025	ARS Pharmaceuticals, Inc.	Director	Sell	17.5	-50,000	-19.21%	✓	$555.1K
Dec 2, 2024	Dec 4, 2024	ARS Pharmaceuticals, Inc.	Director	Sell	15.0	-200,000	-19.19%	✓	$2.7M
Sep 1, 2023	Sep 5, 2023	ARS Pharmaceuticals, Inc.	Director	Sell	7.5	-100,000	-32.22%	✓	$770.5K
Aug 3, 2023	Aug 7, 2023	ARS Pharmaceuticals, Inc.	Director	Sell	26.3	-45,004	-9.66%	✓	$316.5K
Aug 1, 2023	Aug 3, 2023	ARS Pharmaceuticals, Inc.	Director	Sell	22.5	-54,996	-11.56%	✓	$391.8K
Jul 7, 2023	Jul 7, 2023	ARS Pharmaceuticals, Inc.	Director	Sell	37.5	-8,858	-4.04%	✓	$56.4K
Jul 3, 2023	Jul 6, 2023	ARS Pharmaceuticals, Inc.	Director	Sell	22.5	-91,142	-12.62%	✓	$590.5K
Jun 1, 2023	Jun 2, 2023	ARS Pharmaceuticals, Inc.	Director	Sell	17.5	-100,000	-19.21%	✓	$684K
Nov 9, 2022	May 10, 2023	ARS Pharmaceuticals, Inc.	Director	Sell	17.5	-143,896	-18.57%	✓	$780.6K